Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02872012 · ClinicalTrials.gov registry record · Phase 1
Cryoanesthesia for Intravitreal Injections
A Phase 1 study, sponsored by University of Michigan.
- Completed
- Registry status
- Phase 1
- Development phase
- 23
- Enrollment target
NCT02872012 is a Phase 1 study that has completed, run by University of Michigan. The registered enrollment target is 23 participants.
The verdict
NCT02872012, a Phase 1 study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 23 participants
- Enrollment target
Study Summary
The cryoanesthesia (CA) device is designed to provide anesthesia to a focal area on the surface of the eye immediately prior to intraocular injections. The investigators plan to carry out a pilot study to collect preliminary data on the effectiveness of the cryoanesthesia (CA) device in minimizing the pain caused by intravitreal injections (IVT).
Interventions
- DRUG Lidocaine
- DEVICE Cryoanesthesia device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2016-03 |
| Est. Completion | 2018-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02872012
The ClinicalTrials.gov registry entry for NCT02872012 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Lidocaine is the first listed.
NCT02872012 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02872012 about?
NCT02872012 is a clinical study titled "Cryoanesthesia for Intravitreal Injections". The cryoanesthesia (CA) device is designed to provide anesthesia to a focal area on the surface of the eye immediately prior to intraocular injections. The investigators plan to carry out a pilot study to collect preliminary data on the effectiveness of the cryoanesthesia (CA) device in minimizing ...
What is the current status of trial NCT02872012?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 23 participants. The study started on 2016-03. Estimated completion is 2018-06.
What interventions are being tested in trial NCT02872012?
The interventions under investigation include: Lidocaine (DRUG), Cryoanesthesia device (DEVICE).
Who is sponsoring clinical trial NCT02872012?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.